Smartkem, INC Form 4 insider transactions

SmartKem Director Joseph Christopher Lizzio reported gifting 150,000 shares of common stock, reducing his direct beneficial ownership to 419,000 shares.

SmartKem, Inc. Director Steven Denbaars was granted 22,466 stock options with an exercise price of $1.16, vesting over 36 months.

SmartKem Director Melisa Denis was granted 22,466 stock options with an exercise price of $1.16, vesting over 36 months.

SmartKem Director Klaas de Boer was granted 22,466 stock options with an exercise price of $1.16, vesting over 36 months.

SmartKem's Chairman and CEO, Ian Jenks, was granted 160,005 stock options with an exercise price of $1.16, vesting over 36 months.

SmartKem's Chief Financial Officer, Barbra Keck, was granted 71,077 stock options with an exercise price of $1.16, vesting over a 36-month period.

SmartKem, Inc. director Sriram Krishnamurthy Peruvemba was granted 22,466 stock options with an exercise price of $1.16.

SmartKem, Inc.'s Chief Scientist, Beverley Brown, was granted 33,741 stock options with an exercise price of $2.51, following stockholder approval of an amendment to the company's 2021 Equity Incentive Plan.

SmartKem, Inc.'s Chief Financial Officer, Barbra Keck, was granted 75,660 stock options with an exercise price of $2.51 per share, following shareholder approval of an amendment to the company's equity incentive plan.

SmartKem, Inc. director Klaas de Boer was granted 23,915 stock options with an exercise price of $2.51 per share, following shareholder approval of an amendment to the company's 2021 Equity Incentive Plan.

SmartKem, Inc.'s Chief Technology Officer, Simon Ogier, was granted 77,656 stock options with an exercise price of $2.51, following stockholder approval of an amendment to the company's 2021 Equity Incentive Plan.

SmartKem, Inc. Chairman and CEO Ian Jenks was granted 170,320 stock options with an exercise price of $2.51, following shareholder approval of an amendment to the company's 2021 Equity Incentive Plan.

SmartKem, Inc. director Sriram Krishnamurthy Peruvemba was granted 23,915 stock options with an exercise price of $2.51, following shareholder approval of an amendment to the company's 2021 Equity Incentive Plan.

SmartKem, Inc. director Melisa Denis was granted 23,915 stock options with an exercise price of $2.51, following stockholder approval of an amendment to the company's 2021 Equity Incentive Plan.

SmartKem, Inc. director Steven Denbaars was granted 23,915 stock options with an exercise price of $2.51, following shareholder approval of an amendment to the company's 2021 Equity Incentive Plan.

SmartKem, Inc. Chief Operating Officer Jonathan Watkins was granted 131,745 stock options with an exercise price of $2.51, vesting over 36 months, following stockholder approval of an amendment to the company's equity incentive plan.

Director Sriram Krishnamurthy Peruvemba of SmartKem, Inc. reports the acquisition of 20,000 employee stock options.

SmartKem's Chief Technology Officer, Simon Ogier, reports the acquisition of 49,000 employee stock options.

Barbra Keck, CFO of SmartKem, Inc., reports the acquisition of 100,000 employee stock options on June 14, 2024.

SmartKem's Chairman and CEO, Ian Jenks, reports the acquisition of employee stock options.

Director Melisa Denis received employee stock options for 20,000 shares of SmartKem, Inc. on June 14, 2024.

Director Steven Denbaars reports the acquisition of stock options in SmartKem, Inc.

Director Klaas de Boer reports acquisition of 20,000 employee stock options in SmartKem, Inc.

Beverley Brown, Chief Scientist at SmartKem, Inc., reports the acquisition of 49,000 employee stock options.

Director Klaas de Boer converted Series A-2 Convertible Preferred Stock into 5,715 shares of SmartKem, Inc. common stock on May 30, 2024.